Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligation
- 1 July 1997
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 26 (6), 1363-1371
- https://doi.org/10.1016/s0168-8278(97)80473-4
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Pentoxifylline inhibits the proliferation and the fibrogenic properties of human hepatic myofibroblastic cellsHepatology, 1995
- Effect of simvastatin, an inhibitor of hydroxy-methylglutaryl coenzyme a reductase, on the growth of human ito cellsHepatology, 1994
- Effects of low-sodium diet and spironolactone on portal pressure in patients with compensated cirrhosisHepatology, 1994
- Serum hyaluronate reflects hepatic sinusoidal capillarizationGastroenterology, 1993
- Systemic and splanchnic haemodynamic effects of pentifylline in rats with portal hypertensionClinical Science, 1992
- Fibroproliferation in liver disease: Role of monocyte factorsHepatology, 1992
- Sirius Red histophotometry and spectrophotometry of sections in the assessment of the collagen content of liver tissue and its application in growing rat liverLiver International, 1990
- Reduction of intrahepatic vascular space in the pathogenesis of portal hypertensionGastroenterology, 1987
- General Observer-Agreement Measures on Individual Subjects and Groups of SubjectsPublished by JSTOR ,1984
- Chronic Bile Duct Ligation in the Dog: Hemodynamic Characterization of a Portal Hypertensive ModelHepatology, 1983